Sabine Muth
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.
Journal: The Journal of clinical investigation
Published: July 02, 2026
Type I interferon-activated NK cells control polycythemia vera in vivo.
Journal: Blood
Published: March 09, 2026
Extracellular matrix reprogramming by the YAP/TAZ/TGF-β2 axis drives immune exclusion in cholangiocarcinoma models.
Journal: The Journal of clinical investigation
Published: October 21, 2025
The deacetylases HDAC1/HDAC2 control JAK2V617F-STAT signaling through the ubiquitin ligase SIAH2.
Journal: Signal transduction and targeted therapy
Published: November 13, 2024
Cross-presenting Langerhans cells are required for the early reactivation of resident CD8+ memory T cells in the epidermis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 14, 2023
Tumor-infiltrating CCR2+ inflammatory monocytes counteract specific immunotherapy.
Journal: Frontiers in immunology
Published: July 27, 2023
Author Correction: Dithranol as novel co-adjuvant for non-invasive dermal vaccination.
Journal: NPJ vaccines
Published: June 22, 2023
Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection.
Journal: Frontiers in immunology
Published: June 12, 2023
Last Updated: 09/26/2026